Monitor for any subsequent prospectus supplement or takedown announcement, which would reveal the size and pricing of an actual offering. The shelf's effectiveness itself is a routine procedural step, but the overhang may weigh on the stock until the company signals its intentions.
CGEN drugs
CGEN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $2.02entry
- T+1 · 5mo ago −2.97%α −1.39% · $1.96
- T+5 · 5mo ago 0.00%α −2.41% · $2.02
- T+20 · 4mo ago +18.32%α +16.87% · $2.39
- T+60 · 3mo ago +30.20%α +26.38% · $2.63
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Compugen's shelf registration statement on Form F-3 (File No. 333-295989) was declared effective by the SEC on June 8, 2026. This allows the company to offer and sell securities, including common shares, from time to time at its discretion, creating a potential dilution overhang for existing shareholders.
Key Facts
- Shelf registration on Form F-3 (File No. 333-295989) declared effective on June 8, 2026.
- Company can now offer and sell securities (e.g., common shares) at any time without further SEC review.
- No specific offering size, pricing, or timing was disclosed in the effectiveness notice.
Financial Impact
No dollar amount disclosed; potential dilution from future offerings is indeterminate.
Risk Factors
- Future share issuance could dilute existing holders.
- Uncertainty about the timing and size of any offering may create overhang.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001920 |
| Document: 9999999995-26-001920-index.html | 9999999995-26-001920 |
| Document: 9999999995-26-001920.txt | 9999999995-26-001920 |
Track record
9 reports on CGEN
Filters
- Nov 9, 20267d ago 6-K Neutral 4/10 Entry $2.14 Now $2.04 −4.67% settles Dec 8
- Aug 3, 202615w ago 6-K Neutral 2/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Aug 3, 202615w ago 6-K Neutral 4/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Jun 9, 202623w ago EFFECT Neutral 3/10 Viewing Entry $2.02 to $2.39 Now $2.04 +0.99% ▲ +18.32% +16.87% vs SPY
- May 18, 202626w ago 6-K Neutral 4/10 Entry $2.86 to $2.03 Now $2.04 −28.67% ▼ −29.02% −30.60% vs SPY
- Apr 24, 202629w ago Insider Cluster Neutral 2/10 Entry $3.10 to $2.61 Now $2.04 −34.19% ▼ −15.81% −19.83% vs SPY
- Apr 14, 202631w ago Insider Cluster Neutral 2/10 Entry $2.88 to $2.87 Now $2.04 −29.17% ▼ −0.35% −6.64% vs SPY
- Apr 13, 202631w ago 144 Neutral 3/10 Entry $2.76 to $2.87 Now $2.04 −26.09% ▲ +3.99% −3.74% vs SPY
- Mar 26, 202633w ago Insider Cluster Neutral 3/10 Entry $2.06 to $3.10 Now $2.04 −0.97% ▲ +50.49% +39.82% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers